资源描述
|2023 12 04&11.27-12.1 11.27-12.1+0.51%9 300&1 2 12 FDA 3 2024 1&RSV&AD&NASH NASH AD 璟 2 3 4 5 6;CXO 5-U 璟-U-U 1 2 S0680519010001 S0680519010003 1 2023-11-29 2&2023-11-27 3 2023-11-20-32%-16%0%16%2022-12 2023-04 2023-08 2023-11 300 2023 12 04 P.2.4&.6 2.1.6 2.2.7.10 3.1.10 3.1.1.10 3.1.2.12 3.1.3.14 3.1.4.16 3.1.5.18 3.2.19 3.3.23 3.3.1 CXO.23 3.3.2.24 3.3.3.26 3.3.4.27 3.3.5.28 3.3.6.29.31 4.1.31 4.2.34 4.3.35&.37.43 1.6 2.7 3 2020-2024%.7 4 2020-2024%.7 5 2023.8 6 11.24-12.01 VS.VS.300.10 7 2023 VS.VS.300(%).10 8 IND.11 9 NDA.12 10 5 5.13 11 2023 VS.(%).15 12 vs 2023.17 13 vs 2023.18 14.19 15 2023 VS.VS.(%).19 16.20 17.20 18.20 19.21 WUBYwPrMnOmNsMsRnQtMnM7NaO6MtRoOmOoNfQnMtRjMrRnQ6MrRuNuOoPpRMYqRsO 2023 12 04 P.3 20.21 21.22 22 vs 2023.24 23 vs 2023.25 24 5 5.25 25.25 26.29 27.29 28 11.27-12.1 VS.300 VS.31 29 2023 VS.300 VS.(%).31 30%.32 31 2023%.33 32%.33 33 2023%.34 34 PE vs.A-.34 35 2013.35 36.35 37.36 38&2023 12 02.37 2023 12 04 P.4 11.27-12.1 11.27-12.1+0.51%9 300&1 2 12 FDA 3 2024 1&RSV&AD&NASH NASH AD 璟 2 3 4 2023 12 04 P.5 5 6;CXO 7-U 璟-U-U 2023 12 04 P.6&2.1 1/PE 2022A 2023E 2024E 2022A 2023E 2024E 2023E 2024E 257 10.9 11.5 14.6 3%6%27%22 18 375 13-1.33 10.46 14.30-111%-886%37%36 26 203 F627 F652 II 1.91 3.64 5.85-31%91%61%56 35 72 odm 1.83 1.82 2.53 55%-1%39%40 28 391 illumina 20.26 0.03 1.73 319%-100%5667%13033 226 181-4.80-3.21 0.12-686%-33%-104%-56 1508 69 1.05 0.87 1.35 75%-17%55%79 51 328-4.40 3.28 6.34-130%-175%93%100 52 191 K+ADC-6.16-2.76-4.75 31%-55%72%-69-40 112 NASH Firborscan 0.98 1.52 2.20 3%55%45%74 51 234 PD-1 BTLA 3-23.86-17.38-9.69-232%-27%-44%-13-24 103 1.77 2.22 2.90-21%25%31%46 36 571 X8 13.28 16.46 21.18 36%24%29%35 27 178 3.31 4.88 6.29 2%47%29%36 28 371 K-11.68 17.27-3.53-9%-248%-120%21-105 415 CART-2.27-2.28-1.54 37%1%-33%-182-270 75 PEG 1.87 1.66 2.09 6%-11%26%45 36 41 biosimilar-0.90-0.78-0.15-194%-13%-81%-53-273 1183+60 16.56 19.83 24.81 17%20%25%60 48 82 2023 72.41%14.49%1.65 1.83 2.37 32%11%30%45 35 67 ANDA 2.47 2.52 3.05 6%2%21%27 22 58 eLum-1.62-0.53 0.18-24%-67%-134%-109 322 140 11.97 5.36 6.84 89%-55%28%26 20 Wind ioncology Daily wind 20231201 2023 12 04 P.7 2.2 2023 11 24 2023 10 2 1-3 10 5 4-5d 1-7d RSV 3-9d 5 3 5-10d 0-5 5.6d 1-3 3 2020-2024%4 2020-2024%2023 12 04 P.8&1 2 5 2023/2023 2023 12 04 P.9 1 2023H1 TOP 2 C 3 NDA TG-1000 III ZX 7101A III ADC189 II 4 5 2023 12 04 P.10 3.1 3.1.1 1 11.24-12.1 0.47%300 12 1 2,020.90 0.47%0.51%300-1.56%0.03 300 2.03 2023 6.37%2.49%300 10.04%300 7 2023 VS.VS.300(%)Wind-25-20-15-10-5051015 300 6 11.24-12.01 VS.VS.300 11.24-12.01%8,843.95 8,799.41 0.51 2.97-2.49 300 3,482.88 3,538.01-1.56-2.51-10.04 2,020.90 2,011.36 0.47 0.43-6.37 Wind 2023 12 04 P.11 2 11.24-12.1 5-B-B 5-B-B-B-B-B 3 1 GLP-1 2 3 ADC PD-1 4 12 1-1 GLP-1RA Danuglipron PF-06882961 2 IIb NCT04707313 III II 2 Orforglipron 36 14%15%2 Orforglipron 26 9.6%Danuglipron III 11 30 RNA siRNA SYH2053 SYH2053 GalNAc siRNA PCSK9 8 IND CEND-1 CD51 CXHL2301310 HRS-1167 PARP1 CXHL2301326 HRS2398 ATR CXHL2301329 tinengotinib FGFR CXHL2301313 2023 12 04 P.12 9 NDA KRAS G12C CXHS2300105 ALK RET JXHS2300109 GMEP Medical Technology GBA JXHS2300104 5 GLP-1 NASH AD/PD-1/ADC combo Trop-2 Nectin-4 HER-3 ADC 21 6 璟 3.1.2 1 114 11.27-12.1+0.79%0.29%0.88%2023 12 04 P.13 2 11.27-12.1 5 5 橦 10 5 5/%/%17.15-19.28 11.97-16.38 11.55-12.53 11.25 橦-10.86 10.80-10.71 Wind 3&4 1 CDE-A GABAA GABAA 1 GABA KL590586 EP0031 RET A400 Ellipses Pharma FDA RET FDA 20 A400 EP0031 FDA 7 A400 2023 12 04 P.14 5 1+2023/&2 2023 6 1 2 3.1.3 1 11.27-12.01 0.51%0.93%1.43 2023 2.49%3.50%5.99 2023 12 04 P.15 11 2023 VS.(%)wind 2 11.27-12.01 5*ST 5*ST 3 4 1 11 28 11 22 2022 OTC 2 11 30 2023 1 II III 6 80-20-15-10-5051015202023-01-012023-01-062023-01-122023-01-182023-01-312023-02-062023-02-102023-02-162023-02-222023-02-282023-03-062023-03-102023-03-162023-03-222023-03-282023-04-032023-04-102023-04-142023-04-202023-04-262023-05-052023-05-112023-05-172023-05-232023-05-292023-06-022023-06-082023-06-142023-06-202023-06-262023-06-302023-07-062023-07-122023-07-182023-07-242023-07-282023-08-032023-08-092023-08-152023-08-212023-08-252023-08-312023-09-062023-09-122023-09-182023-09-222023-09-282023-10-122023-10-182023-10-242023-10-302023-11-032023-11-092023-11-152023-11-212023-11-272023-12-01 II 2023 12 04 P.16 GLP 5 6 6 3.1.4 1&11.27-12.1+1.02%+0.51%0.52-13.99%-2.49%11.50 2023 12 04 P.17 12 vs 2023 Wind 3+13.2%+4.4%+3.3%3-7.1%-5.9%-5.4%2 RSV HPV GSK RSV 3 1 3 2 mRNA OmicronXBB.1.5 2023 12 1 mRNA mRNA S Omicron XBB Omicron XBB 18 Omicron XBB EG.5 COVID-19-35%-30%-25%-20%-15%-10%-5%0%5%10%15%2023/1/22023/1/132023/2/32023/2/172023/3/32023/3/172023/3/312023/4/142023/4/282023/5/122023/5/262023/6/92023/6/212023/7/72023/7/212023/8/42023/8/182023/9/12023/9/152023/9/282023/10/202023/11/32023/11/172023/12/1 2023 12 04 P.18 4 2023Q1 2023Q2 HPV 13 4 1 5 3.1.5 1&11.27-12.01+7.58%+0.51%7.07+25.33%-2.49%27.82 13 vs 2023 Wind 3+12.99%+9.37%+9.09%-20%-15%-10%-5%0%5%10%15%20%25%30%2023 12 04 P.19 2 14 2 1 3 3.2 1 11.27-12.01 0.51%2.19%1.68 2.88%1.32%1.78%2023 2.49%5.57%1.70%12.16%5.18%0.79%15 2023 VS.VS.(%)Wind-25%-20%-15%-10%-5%0%5%10%15%()()()()()2023 12 04 P.20 2 16%10.62-12.42 10.21-9.92 8.30-7.76 5.29-7.76 4.74-6.51 Wind 17%9.77-7.20 7.55-6.79 6.78-6.38 6.51-4.21 5.60-3.81 Wind 18%11.14*ST-8.91 8.77-5.68 6.94-3.21 6.89-2.19 5.88-2.07 Wind 3 1 Q4 2023Q4 2 2023 12 04 P.21 3 25 A/IVD 3-5/4 19 TMB-2266 FDA 2023 11 30 Gorka Holding GmbH 1.15 3,000 Gorka Holding GmbH 1,000 75%EMT 8 120 2,035 EMT 2,000 100%2,000 100%20 2023 12 04 P.22 21 NPP AMP NMPA II NMPA BP180 NMPA III 147 46 5 1 Q4 Q3 Q4 1 2 3+2 1 2 3 Q4/23Q2+3 1 2+2023 12 04 P.23 4 1/2 IVD 25 2 90%A B+6 1 IVD 2 IVD 3.3 3.3.1 CXO 1 CXO 11.27-12.1-0.47%+0.51%0.98-13.29%-2.49%10.79 2023 12 04 P.24 22 vs 2023 Wind 2 CXO CXO+4.3%+3.7%+3.3%+3.1%+2.8%-8.7%-7.8%-4.9%-4.2%-3.4%3 CXO CXO&CGT CXO 4 CXO C 3.3.2 1 11.27-12.01-0.43%0.51%0.93-3.63%-2.49%1.14-40%-30%-20%-10%0%10%20%30%2023/1/22023/1/132023/2/32023/2/172023/3/32023/3/172023/3/312023/4/142023/4/282023/5/122023/5/262023/6/92023/6/212023/7/72023/7/212023/8/42023/8/182023/9/12023/9/152023/9/282023/10/202023/11/32023/11/172023/12/1 2023 12 04 P.25 23 vs 2023 Wind 2+19.05%+2.14%+2.05%+0.91%+0.24%峆-19.54%-18.23%-12.12%-11.82%-9.34%24 5 5/%/%19.05%峆-19.54%2.14%-18.23%2.05%-12.12%0.91%-11.82%0.24%-9.34%Wind 3 25 SH-337 2 1.8 4(XBB.1.5+BQ.1)mRNA SYS6006.32 SARS-CoV-2 COVID-19 HACCP-20%-15%-10%-5%0%5%10%2023 12 04 P.26 4 1 2020-2022 GLP-1 GLP-1 2 5 3.3.3 1 7 11.27-12.1-0.07%0.58%2 11.27-12.1+3.44%-6.37%3 4 1 2 10%2023 12 04 P.27 2 5 1 2 3.3.4 1 20 11.27-12.1-1.15%1.66%2 11.27-12.1 5 5 3 4 1 CSO 2023 12 04 P.28 2 5 1 2 3.3.5 1 18 11.27-12.1-0.52%1.03%2 11.27-12.1 5 5 3 4 1 2020 2/5 1 2 2023 12 04 P.29 3.3.6 1 wind 2022 11.27-12.01 0.51%-0.22%0.55%2023 2.49%+15.58%16.94%2 26%6.36%-5.10%6.16%-3.30%4.53%-3.03%4.52%-2.31%2.70%-2.22%Wind 3 1 2 4/27 2023 12 04 P.30 5 1 2023/a.R&D 2021 b.biotech+SKU 2 3 6 1 2 2023 12 04 P.31 4.1 11.27-12.1+0.51%9 300+0.51%300-1.56%-0.6%300 2.07 1.11 2023 2.49%300 10.04%17.92%300 29 2023 VS.300 VS.(%)Wind-25-20-15-10-5051015 300 28 11.27-12.1 VS.300 VS.11.27-12.1%8843.95 8799.41 0.51 0.07-2.49 300 3482.88 3538.01-1.56-0.38-10.04 1926.28 1937.94-0.60 0.19-17.92 Wind 2023 12 04 P.32 11.27-12.1 9 2023 12 30%Wind(1.56)0.51-6-5-4-3-2-1 0 1 2 3 4 2023 12 04 P.33 31 2023%Wind 11.27-12.1 II 2.31%II 0.93%32%Wind(10.04)(2.49)-30-20-10 0 10 20 30 40-2-1.5-1-0.5 0 0.5 1 1.5 2 2.5 3 2023 12 04 P.34 2023 7.27%II 15.84%II 3.50%3.63%II 2.25%II 4.09%II 5.57%33 2023%Wind 4.2 PE TTM 28.32 0.12 2005 36.89 8.57 PE A 51.58%1.19 2005 64.02%12.45 34 PE vs.A-Wind-25-20-15-10-5051015202023-01-012023-01-092023-01-162023-01-302023-02-062023-02-132023-02-202023-02-272023-03-062023-03-132023-03-202023-03-272023-04-032023-04-112023-04-182023-04-252023-05-052023-05-122023-05-192023-05-262023-06-022023-06-092023-06-162023-06-232023-06-302023-07-072023-07-232023-07-282023-08-042023-08-112023-08-182023-08-252023-09-012023-09-082023-09-152023-09-222023-10-092023-10-162023-10-232023-10-302023-11-062023-11-132023-11-202023-11-27 II II II II II0%20%40%60%80%100%120%140%160%01020304050607080902005-01-072005-06-072005-11-072006-04-072006-09-072007-02-072007-07-072007-12-072008-05-072008-10-072009-03-072009-08-072010-01-072010-06-072010-11-072011-04-072011-09-072012-02-072012-07-072012-12-072013-05-072013-10-072014-03-072014-08-072015-01-072015-06-072015-11-072016-04-072016-09-072017-02-072017-07-072017-12-072018-05-072018-10-072019-03-072019-08-072020-01-072020-06-072020-11-072021-04-072021-09-072022-02-072022-07-072022-12-072023-05-072023-10-07医药行业相对A 股（剔 除银 行）估 值 溢价 水 平 A 股（剔除银行）的PE 申万医药行业PE 2023 12 04 P.35 11.27-12.1 3899.74 39842.41 9.79%2013 7.25%35 2013 Wind 4.3 11.27-12.1 5 5 5 5 36%19.05-19.28 17.15-16.38 13.16-13.80 13.10-13.11 12.99-12.82 11.97-12.53 11.55-12.12 11.25-11.82 11.14 橦-10.86 10.80-10.54 Wind 0.00%2.00%4.00%6.00%8.00%10.00%12.00%14.00%16.00%18.00%0100020003000400050006000700080009000100002013/01 2014/01 2015/01 2016/01 2017/01 2018/01 2019/01 2020/01 2021/01 2022/01 2023/01 2023 12 04 P.36 37%84.47-24.52 53.22-22.41 45.76-12.65 38.32-10.98 36.17-10.84 34.76-10.56 32.40-9.61 32.27-9.56 橦 28.64-9.18 28.40-8.99 Wind 2023 12 04 P.37&38&2023 12 02 2023 2022 9 26 2023E 2023E PE 2023E 2023Q1 2022Q2 1 1 Biotech 2,085 16%75%-77.75 43%-27 15%-34%450-27%-2%-12.7 47%-35-37%-40%650 31%83%-10.12 54%-64-376-11%49%-10.00 0%-38-13%22%373 56%139%17.27 248%22-56-41%-1%-3.13 4%-18-143 10%65%-3.43-11%-42-119 106%115%-8.33 13%-14-9%-11%璟 130 18%42%-3.09 32%-42 52%-31%197-21%23%-6.77 24%-29 90%-425%190 18%48%-9.37-27%-20-32%0%96 25%47%-3.74 23%-26 2%-5%63-1%4%-33%-8%236 15%40%3.38 133%70-39%-84%234 22%113%-0.14 96%-1694-86 139%163%-2.27-31%-38 7%4%41-37%-17%-2.18 39%-19-28%-32%18-61%-31%-49-38%-17%-7.69 14%-6-52-53%-65%-2,971 21%42%45.4 16%65 0%-25%641-16%3%27.70 9%23-421 9%43%21.2 24%20 178%82%326 12%20%22.5 18%14 5%-14%369 2%47%7.3 15%51-11%35%257 4%78%11.2 24%23 21%6%748-19%-7%37.87 2%20 116%-34%117 14%49%6.89 4%17 10%10%176-35%12%19.30 107%9-861 8%32%27.44 6%31-261 5%40%3.02 9%86 10%32%146 8%47%3.84 25%38-9%29%2 257-11%6%13.4 23%19 1%0%2023 12 04 P.38 111 0%5%4.58 9%24-14%21%201 10%16%13.42 15%15 12%31%235 14%26%17.3 15%14 0%6%67-8%7%2.52 2%26 13%9%64-2%-21%-68%-59%140 16%24%-131%-28%133 17%51%13.21 18%10-200-24%-25%5.25-58%38-77%443%109-1%10%-60%-68%3 416-15%32%24.25 3%17 148%95%229 45%66%9.1 455%25 148%-78%110 1%53%5.73 32%19 29%34%74 1%30%3.80 39%19 42%55%105 26%55%6.2 28%17 34%-46%51 49%114%1.76-39%29 86%54%30-10%30%1.40 25%21-19%24%724 19%22%17.97 26%40 31%12%485 7%42%29.73 21%16 37%-19%328 28%66%10.59 36%31 101%120%275 26%69%10.90 26%25 101%8%283 69%125%9.16 162%31 991%100%183 14%42%11.82 55%15-154 13%16%0.72 118%214 26%100%162 53%89%5.71 49%28 14%-26%141 19%43%6.99 95%20 175%-46%140 63%75%6.92 16%20 31%42%485 7%42%29.73 21%16 37%-19%416-15%32%24.25 3%17 148%95%292 20%48%24.98 15%12 16%5%229 45%66%9.1 455%25 148%-78%141 19%43%6.99 95%20 175%-46%110 1%53%5.73 32%19 29%34%127 6%15%5.89 218%21 61%-33%95 30%40%4.36 21%22 31%118%45 9%43%1.25 24%36 7%0%30-10%30%1.40 25%21-19%24%51 49%114%1.76-39%29 86%54%79 41%72%2.62 30%30 131%-12%30 6%1%3.99 37%8-9%-1%97 36%60%5.50 18%18 10%14%otc 485 7%42%29.73 21%16 37%-19%292 20%48%24.98 15%12 16%5%2023 12 04 P.39 162 24%76%12.02 39%13 85%124%97 16%30%-17%-20%91 22%28%4.73 44%19 41%22%97 36%60%5.50 18%18 10%14%79 41%72%2.62 30%30 131%-12%50 24%33%-10%14%1,521-12%0%31.46 27%48 12%14%905-5%-1%40.71 36%22 66%-44%724 19%22%17.97 26%40 31%12%328 28%66%10.59 36%31 101%120%154 13%16%0.72 118%214 26%100%108 13%28%6.14 28%20 36%-2%106 42%83%5.12 26%21 12%13%74-6%13%3.19 15%23 6%67%95 30%40%4.36 21%22 31%118%4 1,544 11%14%100.17 33%15 6%-60%626-45%-39%38.48-19%16-6%215%375 7%13%10.46 888%36-25%-149%398-38%-34%9.16 26%43 345%33%-U 207-43%-27%-5.75 37%-36-215%-111%105-8%-15%6.25 4%17-22%19%80 41%43%0.59 122%135 157%73%246-14%7%4.51 149%54 6%-32%142 15%-20%-16%-22%43 14%29%-0.12-129%-357 1476%19%5 447 9%37%14.39 34%31 50%73%184 0%14%5.15 19%36 64%81%215 29%67%5.46-7%39-47%-3%522 34%54%11.02 25%47 109%40%86 19%51%2.22 89%39 81%-50%542 29%53%22.04 17%25 31%6%2 1 3,517-5%17%116.27 21%30 22%21%1,183-19%-9%19.83 20%60 8%35%391-15%-3%0.03-100%15443-144%0%222-6%37%4.91 33%45 171%70%88 1%21%0.83 283%106 386%774%72-26%-10%1.82 0%39 35%35%76-46%-59%4.50 18%17 192%0%150-11%1%4.37 9%34 62%0%339 8%35%23.68 48%14 54%-36%168-11%20%4.32 0%39 4%95%125 26%27%7.24 44%17 54%6%2023 12 04 P.40 91 80%118%2.32 85%39 299%-42%47 30%55%1.53 63%31 77%-44%37 15%25%1.28 5%29 54%-27%2 320-25%-8%21.77-1%15 9%-28%195-20%-44%6.50-27%30-41%23%219-31%-34%7.08 13%31 17%-7%207-15%13%3.28 41%63 34%16%189 13%69%4.46 147%42 33%-92%253 24%111%5.08 42%50 54%36%-U 126 1%117%0.20 584%621-5676%0%178 16%45%4.88 48%36 134%7%149 11%52%4.78 34%31 1%10%167-19%-12%6.09 12%27-18%16%106 17%46%2.90-6%36-25%-5%168 19%46%1.88 104%90-48%-63%52-17%-12%1.40-27%37 4%7%56-26%-31%2.04 10%28-3%32%39 43%45%0.57 118%69 2%-1309%29 21%7%0.43 20%68 9%34%32 2%10%-41%-33%3 135-2%8%-283%-85%63 16%17%-110%-98%71-27%-29%4.67-31%15 31%29%65-16%-7%-19%9%45-22%-10%2.06 24%22 35%83%68-42%-44%-70%18%52 8%-3%1.46-10%36-60%148%47-22%-24%2.92-6%16 20%28%42 22%20%2.00 8%21-6%54%32-1%-11%-53%126%4 IVD 571 47%114%16.46 24%35 15%0%314-12%12%12.93 11%24 1%22%120 25%30%5.16 33%23 13%-41%140 0%10%5.36-55%26-77%-31%143 31%49%3.83-62%37-84%203%90 35%116%3.29 26%27 28%39%104 39%72%3.35 33%31 31%14%89-15%-1%2.48-6%36 7%-47%98-6%0%4.57-35%21-42%-7%5 142-20%-11%9.60 13%15 9%-17%68-21%-18%6.66 17%10 4%30%29-25%-6%-26%-4%3 1,586-29%-14%34.59 37%46 28%8%2023 12 04 P.41 324-20%-17%6.87 34%47 34%0%260-47%-32%6.11 11%42 1%-31%92-49%-12%3.74 209%24-114 1%83%2.64 44%43-276-14%12%7.43 56%37-272 47%80%16.56 75%16 64%-43%68 4%13%1.31 122%52 64%0%209-25%-3%-1.64 86%-128 83%5%113-16%-12%-1708%2724%106 0%28%-72%0%4 1 CDMO 1,692-27%-6%52.01 18%33-521-3%4%24.9-25%21 26%351%158-27%-36%10.5-48%15-20%557%253-33%-20%12.4 35%20 35%44%194-22%6%12.3 24%16 57%-15%88-45%-34%4.2 35%21-18%-74%86-26%-31%3.2 66%27-26%32%2 CRO 2,464 4%21%100.04 14%25 32%155%592-26%-2%17.55 28%34 40%5%544-40%-28%23.23 16%23 10%-16%198-36%-36%6.22-42%32 50%307%98-52%-54%2.74-19%36 32%26%77-6%24%2.20 41%35 44%40%70-5%7%2.79 44%25 80%79%36 25%36%0.48 75%75-6%-64%68 38%68%1.70 49%40 8%28%43 47%73%1.23 70%35 160%-45%43-16%-10%-402%26913%67 24%-3%0.30 18%224-33%-100%3 151 59%97%3.0 24%50 16%-12%123 13%47%7.4-2%17 4%24%55-17%-2%2.4 418%23-88%-118%105 5%19%2.9 38%36 12%51%49-22%-1%1.7 64%27 23%-29%81-8%3%3.3 380%25 18%-78%4 388-15%15%14.59 15%27 24%15%296-20%11%13.17 27%22 29%8%178-24%5%9.34 19%19 20%20%152-18%9%11.00 9%14 33%-9%78 0%91%4.16 14%19 144%2%88 21%44%2.74 19%32 30%26%5 664 4%12%52.39-7%13 21%69%2023 12 04 P.42 292 24%43%24.17 16%12 24%-42%77 16%43%8.36 19%9 18%22%231 12%25%21.74 11%11 11%4%90 4%12%8.57-10%11 48%-19%170 22%38%16.64 12%10 44%2%6 86-44%-28%-0.89 76%-97-48%-138%131-34%-28%5.65-6%23 21%22%25-9%5%0.57 28%43 8%-48%25 11%18%-0.37 41%-68-33%-134%7 123-41%-57%1.01-63%122-80%142%69-18%-28%0.87-18%79-4%0%154-25%-30%2.03-59%76-112%230%80-1%-14%1.92-6%42-16%76%114-9%-6%2.81-7%
展开阅读全文